Clinical Trial Update: Comparison of Eohilia With Dupixent on Esophagus Diameter in Patients With Eosinophilic Esophagitis. [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial compares Eohilia with Dupixent to evaluate esophagus diameter in patients with eosinophilic esophagitis. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• DUPIXENT (DUPILUMAB)
• EOHILIA (BUDESONIDE)

Snippet

Sponsor: Mayo Clinic | Conditions: Eosinophilic Esophagitis (EoE) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING